H. Cao

Concurrent use of anlotinib overcomes acquired resistance to EGFR‐TKI in patients with advanced EGFR‐mutant non‐small cell lung cancer

R. Guo, Chenjun Huang, Chen Zhang, 2021, Thoracic cancer.

Reversal of Acquired Resistance to EGFR–TKI in T790M-negative Patients With Non–small-cell Lung Cancer Using Anlotinib

R. Guo, Chenjun Huang, Shidai Jin, 2021 .

Double Philadelphia Chromosome-Positive B Acute Lymphoblastic Leukemia

Tao Wu, H. Bai, Cun-bang Wang, 2018, International Journal of Hematology and Therapy.

Nomogram Based on Systemic Immune-Inflammation Index to Predict Overall Survival in Gastric Cancer Patients

H. Cao, Youqin Jiang, Weiwei Ji, 2018, Disease markers.

Prognostic value of the combined preoperative plasma fibrinogen and systemic inflammatory indexes in ESCC patients

Zhenhua Liu, Miaomiao Zhao, H. Cao, 2023, Discover Oncology.